ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Artificial intelligence in myeloproliferative neoplasms: From digital bone marrow pathology to clinical decision support

Study limitation reported by the research below: “No AI tool reviewed has been prospectively validated to change clinical decision-making or improve patient outcomes in MPN — predictive accuracy should not be equated with clinical utility.”

Papers